Effectiveness of COVID-19 vaccines against severe outcomes in cancer patients: Real-world evidence from self-controlled risk interval and retrospective cohort studies
CONCLUSION: COVID-19 vaccines significantly reduce the risk of severe outcomes in cancer patients, though their efficacy against breakthrough infections is less evident.PMID:38554591 | DOI:10.1016/j.jiph.2024.03.015
Source: Cancer Control - Category: Cancer & Oncology Authors: Hui-Eon Lee Na-Young Jeong Minah Park Eunsun Lim Jeong Ah Kim Heehyun Won Chung-Jong Kim Sang Min Park Nam-Kyong Choi Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Covid Vaccine | COVID-19 | Health Insurance | Insurance | International Medicine & Public Health | Statistics | Study | Vaccines